<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.114209</article-id><article-id pub-id-type="publisher-id">ACM-41495</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210400000_91427776.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  高原地区红细胞与血尿酸浓度变化的研究进展
  Research Progress on Changes of Red Blood Cell and Blood Uric Acid Concentration in Plateau Area
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>卢</surname><given-names>婷</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>翔</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青海大学附属医院，青海 西宁</addr-line></aff><aff id="aff2"><addr-line>青海大学，青海 西宁</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>04</month><year>2021</year></pub-date><volume>11</volume><issue>04</issue><fpage>1460</fpage><lpage>1464</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    高海拔地区空气稀薄，氧分压低，为了适应高原地区的环境，机体的红细胞计数、血红蛋白浓度、血清尿酸水平会发生一系列的变化。长期慢性缺氧的特殊环境下，高原地区人群血清尿酸盐水平普遍增高，给高原人群的健康带来巨大的危害。本文将对高原地区红细胞增多与血尿酸浓度变化进行综述，进一步了解高原缺氧环境下红细胞增多引起尿酸升高的原因。为高原地区早发现、早诊断、早预防高尿酸血症提供依据。提高高原地区的临床医生及患者对尿酸指标升高的认识，对于高原地区血尿酸升高患者尽早采取预防和干预措施，有效改善高原地区患者的预后，提高生活质量。
    In order to adapt to the plateau environment, the red blood cell count, hemoglobin concentration and serum uric acid level will have a series of changes. Under the special environment of chronic hypoxia for a long time, the level of serum uric acid in people at high altitude is generally increased, which brings great harm to the health of people at high altitude. In this paper, we will review the relationship between polycythemia and the change of serum uric acid concentration at high altitude, so as to further understand the causes of the increase of uric acid caused by polycythemia at high altitude to provide basis for early detection, early diagnosis and early prevention of hyperuricemia in plateau area. In order to improve the prognosis and quality of life of patients at high altitude, it is necessary to improve the awareness of clinicians and patients on the increase of uric acid index, and take preventive and intervention measures as soon as possible. 
  
 
</p></abstract><kwd-group><kwd>高原地区，红细胞，尿酸，高尿酸血症, Plateau Area</kwd><kwd> Red Blood Cell</kwd><kwd> Uric Acid</kwd><kwd> Hyperuricemia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>高海拔地区空气稀薄，氧分压低，为了适应高原地区的环境，机体的红细胞计数、血红蛋白浓度、血清尿酸水平会发生一系列的变化。长期慢性缺氧的特殊环境下，高原地区人群血清尿酸盐水平普遍增高，给高原人群的健康带来巨大的危害。本文将对高原地区红细胞增多与血尿酸浓度变化进行综述，进一步了解高原缺氧环境下红细胞增多引起尿酸升高的原因。为高原地区早发现、早诊断、早预防高尿酸血症提供依据。提高高原地区的临床医生及患者对尿酸指标升高的认识，对于高原地区血尿酸升高患者尽早采取预防和干预措施，有效改善高原地区患者的预后，提高生活质量。</p></sec><sec id="s2"><title>关键词</title><p>高原地区，红细胞，尿酸，高尿酸血症</p></sec><sec id="s3"><title>Research Progress on Changes of Red Blood Cell and Blood Uric Acid Concentration in Plateau Area</title><p>Ting Lu<sup>1</sup>, Xiang Zhang<sup>2*</sup></p><p><sup>1</sup>Qinghai University, Xining Qinghai</p><p><sup>2</sup>Qinghai University Affiliated Hospital, Xining Qinghai</p><p><img src="//html.hanspub.org/file/2-1572091x5_hanspub.png" /></p><p>Received: Mar. 6<sup>th</sup>, 2021; accepted: Mar. 30<sup>th</sup>, 2021; published: Apr. 9<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/2-1572091x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>In order to adapt to the plateau environment, the red blood cell count, hemoglobin concentration and serum uric acid level will have a series of changes. Under the special environment of chronic hypoxia for a long time, the level of serum uric acid in people at high altitude is generally increased, which brings great harm to the health of people at high altitude. In this paper, we will review the relationship between polycythemia and the change of serum uric acid concentration at high altitude, so as to further understand the causes of the increase of uric acid caused by polycythemia at high altitude to provide basis for early detection, early diagnosis and early prevention of hyperuricemia in plateau area. In order to improve the prognosis and quality of life of patients at high altitude, it is necessary to improve the awareness of clinicians and patients on the increase of uric acid index, and take preventive and intervention measures as soon as possible.</p><p>Keywords:Plateau Area, Red Blood Cell, Uric Acid, Hyperuricemia</p><disp-formula id="hanspub.41495-formula8"><graphic xlink:href="//html.hanspub.org/file/2-1572091x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/2-1572091x8_hanspub.png" /> <img src="//html.hanspub.org/file/2-1572091x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 前言</title><p>由于我国临床医生和患者对血尿酸(Serum Uric Acid, SUA)升高的认识和重视程度低，对HUA和痛风的诊断、治疗及预防可能存在一些盲区和误区。最新研究结果显示中国高尿酸血症(HUA)发病率呈明显上升和年轻化趋势，已成为继糖尿病、高血压、高脂血症后的“第四高” [<xref ref-type="bibr" rid="hanspub.41495-ref1">1</xref>]。国外研究指出2015~2016年，美国成年人中痛风的总患病率为3.9%。HUA见于14.6%的美国人口，男性HUA (24.7%)比女性(5.2%)更常见 [<xref ref-type="bibr" rid="hanspub.41495-ref2">2</xref>]。在全世界范围内HUA从0.1%到10%不等，在许多发达国家似乎还在增加 [<xref ref-type="bibr" rid="hanspub.41495-ref3">3</xref>]。当SUA浓度超过溶解度阈值时则发展为HUA，当SUA水平超过正常生理条件下的溶解度极限时，可形成尿酸单钠晶体(MUS)。MUS可引起局部炎症和组织损伤(即痛风发作) [<xref ref-type="bibr" rid="hanspub.41495-ref4">4</xref>]。在无炎症发作的情况下HUA被称为无症状性高尿酸血症 [<xref ref-type="bibr" rid="hanspub.41495-ref5">5</xref>]。历史上，无症状高尿酸血症被认为是良性的实验室发现，在没有痛风或肾结石的情况下临床意义不大。HUA公认的后果是痛风和肾结石的风险增加，在循证医学指南中，目前只推荐对有症状的HUA进行治疗。然而，越来越多的证据表明，无症状高尿酸血症可以预测高血压、肥胖、糖尿病、代谢综合征、脂肪肝和慢性肾脏疾病的发展，并可能通过刺激炎症而促进疾病的发生。虽然历史上认为HUA是继发于这些疾病的，但有证据表明，HUA先于这些疾病的发生。日本队列中的一项研究发现，在健康、瘦弱、血压正常的个体中存在HUA仍然会增加患心脏代谢性疾病(如高血压、血脂异常、体重过剩和慢性肾脏疾病)的风险 [<xref ref-type="bibr" rid="hanspub.41495-ref3">3</xref>]。</p><p>目前国内有高原红细胞增多症(HAPC)引发痛风病例的文献报道 [<xref ref-type="bibr" rid="hanspub.41495-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.41495-ref7">7</xref>]，有报道在HUA的病因明确中，HAPC为第4位 [<xref ref-type="bibr" rid="hanspub.41495-ref8">8</xref>]。国外已有相关研究报道缺氧是增加SUA产量的有力刺激因素，从而增加了高海拔地区的SUA水平，缺氧引起的UA增加的主要来源是腺苷的分解 [<xref ref-type="bibr" rid="hanspub.41495-ref9">9</xref>]。同时国内也有文献报道SUA随着海拔的升高而升高 [<xref ref-type="bibr" rid="hanspub.41495-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.41495-ref11">11</xref>]，HUA可能与低氧刺激的红细胞增生相关 [<xref ref-type="bibr" rid="hanspub.41495-ref12">12</xref>]。高原地区长期慢性缺氧的特殊环境下，使得这一地区人群SUA普遍增高，给高原人群的健康带来巨大的危害。在国内建议对于高原人群，建议定期进行筛查，通过检测血尿酸，及早发现HUA。控制目标：血尿酸 &lt; 360 umol/L (对于有痛风发作的患者，血尿酸宜 &lt; 300 umol/L)。干预治疗切点：血尿酸 &gt; 420 umol/L(男)，&gt;360 umol/L (女) [<xref ref-type="bibr" rid="hanspub.41495-ref10">10</xref>]。以下对HAPC导致UA增高原因进行分析。</p></sec><sec id="s6"><title>2. 高原地区红细胞增多</title><p>在高原慢性缺氧环境下，低氧、低气压严重威胁高原人群的健康，由于高海拔地区气压的降低导致动脉血中氧分压和血红蛋白的氧饱和度降低引起低氧血症的发生，导致组织缺氧。缺氧会使缺氧诱导因子2α(HIF-2α)的α亚基增多，HIF-2α与HIF-1β结合形成异二聚。异二聚体与EPO基因的缺氧反应元件结合，以刺激转录并增加EPO的合成。EPO促进骨髓中红细胞的成熟和增殖，促进血红蛋白的浓度升高 [<xref ref-type="bibr" rid="hanspub.41495-ref13">13</xref>]。红细胞计数和血红蛋白浓度随着海拔高度的升高而升高，当红细胞升高到一定程度时，就会发展成HAPC [<xref ref-type="bibr" rid="hanspub.41495-ref14">14</xref>]。HAPC在高原地区普遍存在，这是机体对慢性缺氧的一种生理性代偿反应。可红细胞增多在保护机体的同时是否会给机体带来一定的危害呢？</p></sec><sec id="s7"><title>3. 红细胞脱去细胞核</title><p>在高原地区，缺氧刺激骨髓造血，红细胞从原始红细胞到成熟红细胞阶段会排出细胞核。Goto T.等 [<xref ref-type="bibr" rid="hanspub.41495-ref15">15</xref>] 研究了不同氧气环境下红细胞的分化程度得出，在缺氧条件下红细胞终末分化时的去核率，细胞内三磷酸腺苷(ATP)、乳酸脱氢酶(LDH)M<sub>3</sub>H和HIF-1a水平均比常规氧气条件下高。同时，Miyanishi M.等 [<xref ref-type="bibr" rid="hanspub.41495-ref16">16</xref>] 研究发现红细胞生成发生在骨髓或者胎儿肝脏的“血岛”，血岛中含有红细胞与中央巨噬细胞，在确定性红细胞生成中，细胞核从红系前体细胞中排出并表达磷脂酰丝氨酸，作为吞噬细胞的吞噬信号，被血岛中的巨噬细胞吞噬。Yoshida H.等 [<xref ref-type="bibr" rid="hanspub.41495-ref17">17</xref>] 通过研究小鼠脾脏中分离出的晚期红细胞的去核和吞噬机制得出：在培养晚期红细胞时发现细胞核自发地从红细胞中突出，以微弱的物理力将细胞核与网织红细胞分离。释放的细胞核很快在其表面暴露出磷脂酰丝氨酸，利于巨噬细胞有效吞噬细胞核。这一发现印证了红细胞去核后被巨噬细胞吞噬的这一事实。那被吞噬后的细胞核去哪儿了？</p></sec><sec id="s8"><title>4. 红细胞引起尿酸增高途径</title><sec id="s8_1"><title>4.1. 红细胞核降解直接引起尿酸升高</title><p>Okabe Y.等 [<xref ref-type="bibr" rid="hanspub.41495-ref18">18</xref>] 研究指出巨噬细胞中含有脱氧核糖核酸酶(DNase) II，DNase II是一种溶酶体酶，在酸性pH下功能最佳，在巨噬细胞中的表达尤为突出。该酶可裂解被吞噬的凋亡细胞的DNA和红细胞前体细胞排出的细胞核。同时，Evans C.等 [<xref ref-type="bibr" rid="hanspub.41495-ref19">19</xref>] 在对降解过程中产生的DNA链末端分析报告中指出，3’-磷酸末端核苷酸中有72%是嘌呤碱基，其中鸟嘌呤占44%，腺嘌呤占28%。5’-羟基末端核苷酸，嘌呤碱基占56%，但胸腺嘧啶只占13%。除末端外，还检测了5’-羟基倒数第二个核苷酸，在这个位置，嘌呤碱基占75%，腺嘌呤占52%，鸟嘌呤占23%。由此可见红细胞核DNA中嘌呤碱基含量相对较多，故降解后产生较多的嘌呤碱基，而嘌呤碱基的终末代谢产物为UA，这直接引起UA升高。</p></sec><sec id="s8_2"><title>4.2. 成熟红细胞间接引起尿酸升高</title><p>红细胞排出细胞核后分化成熟，成熟后它失去了细胞核、核糖体和线粒体，因此失去了所有的细胞分裂、蛋白质合成和基于线粒体的氧化反应的能力 [<xref ref-type="bibr" rid="hanspub.41495-ref20">20</xref>]。葡萄糖是成熟红细胞利用的唯一燃料，主要通过无氧糖酵解代谢后约80%~90%转化为乳酸 [<xref ref-type="bibr" rid="hanspub.41495-ref21">21</xref>]。乳酸和UA同属酸性物质，血乳酸升高能竞争性抑制UA在肾脏的排泄 [<xref ref-type="bibr" rid="hanspub.41495-ref6">6</xref>]，从而使UA排出减少，间接引起UA升高。此外在高原地区，在缺氧状态下，ATP被分解成AMP增强，嘌呤碱进一步分解为腺苷、肌苷和次黄嘌呤，使得嘌呤代谢途径增强。与此同时，慢性缺氧条件下黄嘌呤脱氢酶转化为黄嘌呤氧化酶而导致黄嘌呤氧化酶活性增加，黄嘌呤氧化酶催化次黄嘌呤氧化使得UA增多 [<xref ref-type="bibr" rid="hanspub.41495-ref5">5</xref>]。</p></sec></sec><sec id="s9"><title>5. 尿酸对红细胞的作用</title><p>高原慢性低压缺氧环境下，人类红细胞作为O<sub>2</sub>和CO<sub>2</sub>转运体，经常暴露在活性氧(ROS)和氧化应激下。当ROS浓度超过抗氧化保护时，细胞或组织中就会发生氧化应激，细胞外抗氧化能力和细胞外氧化剂的减少使红细胞对压力做出反应，形成棘行或球形红细胞 [<xref ref-type="bibr" rid="hanspub.41495-ref21">21</xref>]。UA是血浆中主要的抗氧化分子，血浆一半以上的抗氧化能力来自UA，它的抗氧化活性已逐渐取代抗坏血酸，成为主要的水溶性抗氧化剂 [<xref ref-type="bibr" rid="hanspub.41495-ref9">9</xref>]。El Ridi R.等 [<xref ref-type="bibr" rid="hanspub.41495-ref22">22</xref>] 指出UA是ROS与过氧亚硝酸盐的清除剂和抗氧化剂。在红细胞对UA的摄取中表明，UA通过其离子螯合活性和与铁离子形成稳定的配位复合物来抑制Fenton反应，从而抑制ROS的产生 [<xref ref-type="bibr" rid="hanspub.41495-ref23">23</xref>]。Song Y.等 [<xref ref-type="bibr" rid="hanspub.41495-ref24">24</xref>] 研究指出在UA的抗氧化作用中，UA水平与红细胞计数和总血红蛋白浓度之间存在显著的正相关，UA可能通过特异性转运蛋白或通过细胞膜扩散作用进入红细胞，通过抗氧化作用保护红细胞免受氧化应激损伤，维持红细胞形态，从而阻止棘细胞和球形红细胞的形成。UA还能保护红细胞免受修饰，防止蛋白质羰基化，保护蛋白质免受氧化修饰。由此可见，UA在红细胞中具有较强得抗氧化作用，维持红细胞得携氧能力。那是否UA与红细胞之间彼此相互促进同时升高，这需要大量的流行病学调查研究进一步明确二者之间的相关性。</p></sec><sec id="s10"><title>6. 结语</title><p>综上所述，在高原慢性缺氧条件下红细胞增多可直接或间接引起UA增高，若不及时降UA治疗则会导致HUA乃至痛风的发生。但UA的抗氧化作用可保护红细胞免受氧化应激的损伤，维持红细胞携氧能力，减轻缺氧症状的同时，UA还与痛风、肾结石、慢性肾脏病、心脑血管疾病、糖尿病、高血压等疾病密切相关。故高原地区因高度重视红细胞增多以及UA水平，必要时予以降UA治疗，减少UA引起的不良预后及相关并发症的发生。</p></sec><sec id="s11"><title>文章引用</title><p>卢 婷,张 翔. 高原地区红细胞与血尿酸浓度变化的研究进展Research Progress on Changes of Red Blood Cell and Blood Uric Acid Concentration in Plateau Area[J]. 临床医学进展, 2021, 11(04): 1460-1464. https://doi.org/10.12677/ACM.2021.114209</p></sec><sec id="s12"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.41495-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">林淑芃. 《中国高尿酸血症与痛风诊疗指南(2019)》解读[J]. 临床内科杂志, 2020, 37(6): 460-462.</mixed-citation></ref><ref id="hanspub.41495-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Singh, G., Lingala, B. and Mithal, A. (2019) Gout and Hyperuricaemia in the USA: Prevalence and Trends. Rheumatology, 58, 2177-2180. &lt;br&gt;https://doi.org/10.1093/rheumatology/kez196</mixed-citation></ref><ref id="hanspub.41495-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Joosten, L., Crişan, T.O., Bjornstad, P. and Johnson, R.J. (2020) Asymptomatic Hyperuricaemia: A Silent Activator of the Innate Immune System. Nature Reviews Rheumatology, 16, 75-86. &lt;br&gt;https://doi.org/10.1038/s41584-019-0334-3</mixed-citation></ref><ref id="hanspub.41495-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Dalbeth, N., Merriman, T.R. and Stamp, L.K. (2016) Gout. Lancet, 388, 2039-2052.  
&lt;br&gt;https://doi.org/10.1016/S0140-6736(16)00346-9</mixed-citation></ref><ref id="hanspub.41495-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Jefferson, J.A., Escudero, E., Hurtado, M.E., Pando Kelly, J., Swenson, E.R., Wener, M.H., et al. (2002) Hyperuricemia, Hypertension, and Proteinuria Associated with High-Altitude Polycythemia. American Journal of Kidney Diseases, 39, 1135-1142. &lt;br&gt;https://doi.org/10.1053/ajkd.2002.33380</mixed-citation></ref><ref id="hanspub.41495-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">王栋军, 方海宴. 高原红细胞增多症致痛风19例[J]. 临床军医杂志, 2003, 31(3): 110.</mixed-citation></ref><ref id="hanspub.41495-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">甘立宇, 周洁. 西藏日喀则地区痛风268例分析[J]. 高原医学杂志, 2006, 16(2): 42-44.</mixed-citation></ref><ref id="hanspub.41495-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">杨聪, 黄谦, 冯国君, 刘云祥. 西藏某地区体检人群高尿酸血症分析[J]. 西南国防医药, 2010, 20(2): 226-227.</mixed-citation></ref><ref id="hanspub.41495-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sinha, S., Singh, S.N. and Ray, U.S. (2009) Total Antioxidant Status at High Altitude in Lowlanders and Native Highlanders: Role of Uric Acid. High Altitude Medicine &amp; Biology, 10, 269-274. &lt;br&gt;https://doi.org/10.1089/ham.2008.1082</mixed-citation></ref><ref id="hanspub.41495-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">中华医学会内分泌学分会. 高尿酸血症和痛风治疗的中国专家共识[J]. 中华内分泌代谢杂志, 2013, 29(11): 913-920.</mixed-citation></ref><ref id="hanspub.41495-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">阿祥仁, 周健武. 高原地区体检人群血尿酸水平和高尿酸血症调查研究[J]. 中华检验医学杂志, 2018, 41(6): 462-465.</mixed-citation></ref><ref id="hanspub.41495-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">邬云红, 刘琳, 潘柏莉, 向省平, 陈艳, 李晓萍. 地处平原的高原世居藏族人群血尿酸与血红蛋白水平的相关性研究[J]. 中国全科医学, 2015, 18(7): 792-796.</mixed-citation></ref><ref id="hanspub.41495-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Gassmann, M., Mairbäurl, H., Livshits, L., Seide, S., Hackbusch, M., Malczyk, M., et al. (2019) The Increase in Hemoglobin Concentration with Altitude Varies among Human Populations. Annals of the New York Academy of Sciences, 1450, 204-220. &lt;br&gt;https://doi.org/10.1111/nyas.14136</mixed-citation></ref><ref id="hanspub.41495-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">刘成海, 吕国志, 吴彦民, 杨聪, 杨五洪, 文朝远. 浅析高原红细胞增多与血尿酸的关系[J]. 西南军医, 2017, 19(5): 407-408.</mixed-citation></ref><ref id="hanspub.41495-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Goto, T., Ubukawa, K., Kobayashi, I., Sugawara, K., Asanuma, K., Sasaki, Y., et al. (2019) ATP Produced by Anaerobic Glycolysis Is Essential for Enucleation of Human Erythroblasts. Experimental Hematology, 72, 14-26.e1.  
&lt;br&gt;https://doi.org/10.1016/j.exphem.2019.02.004</mixed-citation></ref><ref id="hanspub.41495-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T. and Nagata, S. (2007) Identification of Tim4 as a Phosphatidylserine Receptor. Nature, 450, 435-439. &lt;br&gt;https://doi.org/10.1038/nature06307</mixed-citation></ref><ref id="hanspub.41495-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Yoshida, H., Kawane, K., Koike, M., Mori, Y., Uchiyama, Y. and Nagata, S. (2005) Phosphatidylserine-Dependent Engulfment by Macrophages of Nuclei from Erythroid Precursor Cells. Nature, 437, 754-758.  
&lt;br&gt;https://doi.org/10.1038/nature03964</mixed-citation></ref><ref id="hanspub.41495-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Okabe, Y., Kawane, K., Akira, S., Taniguchi, T. and Nagata, S. (2005) Toll-Like Receptor-Independent Gene Induction Program Activated by Mammalian DNA Escaped from Apoptotic DNA Degradation. Journal of Experimental Medicine, 202, 1333-1339. &lt;br&gt;https://doi.org/10.1084/jem.20051654</mixed-citation></ref><ref id="hanspub.41495-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Evans, C.J. and Aguilera, R.J. (2003) DNase II: Genes, Enzymes and Function. Gene, 322, 1-15.  
&lt;br&gt;https://doi.org/10.1016/j.gene.2003.08.022</mixed-citation></ref><ref id="hanspub.41495-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Bratosin, D., Estaquier, J., Petit, F., Arnoult, D., Quatannens, B., Tissier, J.-P., et al. (2001) Programmed Cell Death in Mature Erythrocytes: A Model for Investigating Death Effector Pathways Operating in the Absence of Mitochondria. Cell Death &amp; Differentiation, 8, 1143-1156. &lt;br&gt;https://doi.org/10.1038/sj.cdd.4400946</mixed-citation></ref><ref id="hanspub.41495-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Cimen, M.Y. (2008) Free Radical Metabolism in Human Erythrocytes. Clinica Chimica Acta, 390, 1-11.  
&lt;br&gt;https://doi.org/10.1016/j.cca.2007.12.025</mixed-citation></ref><ref id="hanspub.41495-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">El Ridi, R. and Tallima, H. (2017) Physiological Functions and Pathogenic Potential of Uric Acid: A Review. Journal of Advanced Research, 8, 487-493. &lt;br&gt;https://doi.org/10.1016/j.jare.2017.03.003</mixed-citation></ref><ref id="hanspub.41495-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Tzounakas, V.L., Georgatzakou, H.T., Kriebardis, A.G., Papageorgiou, E.G., Stamoulis, K.E., Foudoulaki-Paparizos, L.E., et al. (2015) Uric Acid Variation among Regular Blood Donors Is Indicative of Red Blood Cell Susceptibility to Storage Lesion Markers: A New Hypothesis Tested. Transfusion, 55, 2659-2671. &lt;br&gt;https://doi.org/10.1111/trf.13211</mixed-citation></ref><ref id="hanspub.41495-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Song, Y., Tang, L., Han, J., Gao, Y., Tang, B., Shao, M., et al. (2019) Uric Acid Provides Protective Role in Red Blood Cells by Antioxidant Defense: A Hypothetical Analysis. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 3435174. &lt;br&gt;https://doi.org/10.1155/2019/3435174</mixed-citation></ref></ref-list></back></article>